Editor @TheBullished. Ex-Forbes reporter/editor, UNC Chapel Hill, Columbia MBA. Bringing smart coverage and analysis to every corner of the stock market.
Deals
ESCO paid $922 million in cash plus 5.10 million shares to acquire Megger from TBG AG on Thursday, drawing about $1.0 billion across three new credit facilities.
SEC Filings
An 8-K filed Friday shows Annaly redeemed every share of its 6.750% Series I preferred stock on October 1, folding the class entirely into common equity.
Insider Trades
The Thursday sale is the latest in a months-long program that has now moved more than $114 million of Seagate stock since September.
SEC Filings
Chad J. Swanson notified Prothena on Friday that he is leaving October 9 to take a leadership role at one of the biotech's own partners.
Insider Trades
The Thursday sale is Mosley's fifth Form 4 disclosure since September 1, bringing his total disposals over that stretch to roughly $121.4 million.
SEC Filings
Jones notified Coinbase of her retirement on Tuesday and will stay in her role until a successor is found and responsibilities are handed off.
SEC Filings
The cloud data company split the debt into two tranches — $2.0 billion due 2029 and $1.75 billion due 2031 — with no regular interest on either.
SEC Filings
The delayed-draw facility, signed Friday, carries no borrowed balance yet and expires undrawn if unused by January 29, 2027.
SEC Filings
The 364-day senior term loan, arranged by Citibank, replaces a matching slice of the $4.4 billion bridge commitment Flex secured in September.
SEC Filings
A federal judge let most of Joby Aviation's trade-secret claims against Archer proceed while tossing Archer's counterclaims entirely.
SEC Filings
The amended agreement, valued at roughly $5.7 billion, replaces an all-stock deal signed in June that had been worth about $7 billion.
SEC Filings
The 4SIGHT trial targets 514 patients with diabetic macular edema, backed by FDA advanced therapy designation for 4D-150.